26266-57-9

26266-57-9 structure

Name: Span 40
Chemical Name: Sorbitan monopalmitate
CAS Number: 26266-57-9
Molecular Formula: C₂₂H₄₂O₆
Molecular Weight: 402.565
Catalog: Surfactant Nonionic surfactant Polyol ester type
Create Date: 2018-10-03 19:43:33
Modify Date: 2024-01-02 10:58:25
Sorbitan monopalmitate is used for niosomes particle preparation. Sorbitan monopalmitate can be used as an excipient, such as nonionic surfactants, emulsifiers. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1][2].

Name	Sorbitan monopalmitate
Synonyms	1,4-Anhydro-6-O-palmitoyl-D-glucitol Sorbitan, monohexadecanoate montane40 SPAN NO 40 emsorb2510 Sorbitan Monopalmitate sorgen70 EINECS 247-568-8 liposorbp (Sorbitan MonopalMitate) 1,4-anhydro-6-O-hexadecanoyl-D-glucitol 1,4-Anhydro-D-glucitol, 6-hexadecanoate D-Glucitol, 1,4-anhydro-, 6-hexadecanoate glycomulp MFCD00080946 SPAN(R) 40 ARLACEL 40 D-Glucitol, 1,4-anhydro-6-O-(1-oxohexadecyl)- crill2 Span 40

Description	Sorbitan monopalmitate is used for niosomes particle preparation. Sorbitan monopalmitate can be used as an excipient, such as nonionic surfactants, emulsifiers. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs[1][2].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
References	[1]. Essa E A. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes[J]. Asian Journal of Pharmaceutics (AJP), 2010, 4(4). [2]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016 May 25;87:88-99.

REFERENCE :: JACTDZ Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. Volume(issue)/page/year: 4(3),65,1985

REFERENCE :: JACTDZ Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. Volume(issue)/page/year: 4(3),65,1985 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M1485 No. of Facilities: 619 (estimated) No. of Industries: 16 No. of Occupations: 23 No. of Employees: 25049 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M1485 No. of Facilities: 397 (estimated) No. of Industries: 12 No. of Occupations: 21 No. of Employees: 22189 (estimated) No. of Female Employees: 13283 (estimated)

Personal Protective Equipment	dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes	Xi:Irritant;
Risk Phrases	R36/37/38
Safety Phrases	S26-S36
RIDADR	NONH for all modes of transport
WGK Germany	1
RTECS	WG2932900
HS Code	2932190090

HS Code	2932190090
Summary	2932190090 other compounds containing an unfused furan ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%